Editorial for the Special Issue “Current Research on Cancer Biology and Therapeutics”-Reference-Cited by-同舟云学术

Editorial for the Special Issue “Current Research on Cancer Biology and Therapeutics”

Published:2024-02-28 Issue:5 Volume:25 Page:2802
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Coveñas Rafael¹^ORCID

Affiliation:

1. Laboratory of Neuroanatomy of the Peptidergic Systems, Institute of Neurosciences of Castilla and León (INCYL), University of Salamanca, 37007 Salamanca, Spain

Abstract

Cancer is a major health problem, in 2020 caused 10 million deaths and in 2040, 28,4 million patients suffering from the disease are expected [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/1422-0067/25/5/2802/pdf

Reference14 articles.

1. Global cancer statistic 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Park, Y.-R., Jee, W., Park, S.-M., Kim, S.-W., Jung, J.-H., Kim, H., Kim, K.-I., and Jang, H.-J. (2023). Acetylcorynoline induces apoptosis and G2/M phase arrest through the c-myc signaling pathway in colon cancer cells. Int. J. Mol. Sci., 24.

3. Ferreira, J.C.C., Granja, S., Almeida, A.F., Baltazar, F., Gonçalves, M.S.T., Preto, A., and Sousa, M.J. (2023). Targeting lysosomes in colorectal cancer: Exploring the anticancer activity of a new benzo[a]phenoxazine derivative. Int. J. Mol. Sci., 24.

4. Chang, H.-S., Kim, Y., Lee, S.Y., Yun, H.J., Chang, H.-J., and Park, K.C. (2023). Anti-cancer SERCA inhibitors targeting sorafenib-resistant human papillary thyroid carcinoma. Int. J. Mol. Sci., 24.

5. Kim, Y., Yun, H.J., Choi, K.H., Kim, C.W., Lee, J.H., Weicker, R., Kim, S.-M., and Park, K.C. (2023). Discovery of new anti-cancer agents against patient-derived sorafenib-resistant papillary thyroid cancer. Int. J. Mol. Sci., 24.